Justin Clay, PA
Physician Assistant · Charleston, WVNPI 1548669005
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 469 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Novo Nordisk at 25.1% of the total. Reporting peaked in 2024 at $2,263 and has fallen 70.0% since, to $679 in 2025. Among physician assistant clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 469 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$938
- Lilly USA, LLC$759
- AstraZeneca$634
- Bayer$400
- Merck$309
- plus $2K from 29 others
What the payments were for
- Food & beverage$7,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 161 | $1,784 |
| AbbVie | 58 | $938 |
| Lilly USA, LLC | 46 | $759 |
| AstraZeneca | 29 | $634 |
| Bayer | 29 | $400 |
| Merck | 16 | $309 |
| Sanofi-aventis U.S. LLC | 16 | $225 |
| Boehringer Ingelheim | 14 | $214 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $199 |
| GSK | 11 | $174 |
| Dexcom, Inc. | 10 | $172 |
| Shield Therapeutics Inc | 3 | $135 |
| Novartis | 5 | $97 |
| Lundbeck LLC | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Kowa Pharmaceuticals America, Inc. | 5 | $71 |
| Amgen(2 entities) | 4 | $70 |
| Astellas Pharma US Inc | 4 | $70 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 5 | $59 |
| Exact Sciences | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Johnson & Johnson | 3 | $53 |
| Pfizer | 2 | $50 |
| Lexicon Pharmaceuticals, Inc. | 2 | $42 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $33 |
| Abbott | 2 | $31 |
| Scpharmaceuticals Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Abiomed | 1 | $20 |
| Davol Inc. | 1 | $17 |
| Cequr Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,093 in reported general payments places this provider in the 95th percentile of 833 physician assistant providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 118 | $125,259 |
| OzempicSemaglutide | 68 | $102,048 |
| XareltoRivaroxaban | 54 | $76,152 |
| JardianceEmpagliflozin | 45 | $59,797 |
| JanuviaSitagliptin Phosphate | 53 | $57,091 |
| FarxigaDapagliflozin Propanediol | 24 | $34,225 |
| MounjaroTirzepatide | 26 | $29,576 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $29,277 |
| Repatha SureclickEvolocumab | 26 | $25,802 |
| TradjentaLinagliptin | 21 | $18,558 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $15,933 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $13,840 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $11,814 |
| LinzessLinaclotide | 13 | $9,767 |
| EntrestoSacubitril/Valsartan | 12 | $9,303 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $50 | $125,259118 claims |
| Novo NordiskOzempic | $1,784 | $102,04868 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $214 | $86,07781 claims |
| Johnson & JohnsonXarelto | $53 | $76,15254 claims |
| MerckJanuvia | $309 | $57,09153 claims |
| AstraZenecaFarxiga, Symbicort | $634 | $41,03543 claims |
| Lilly USA, LLCMounjaro | $759 | $29,57626 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $174 | $28,95848 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $225 | $11,81413 claims |
| AbbVieLinzess, Synthroid | $938 | $11,30334 claims |
| NovartisEntresto | $97 | $9,30312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Charleston
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Jason TrustyCharleston$11K
- Kelley DotsonCharleston$8K
- Randi DillonCharleston$7K
- Ashley MuellerCharleston$5K
- Yevgeniya GurevichCharleston$5K
- Morgan MeeksCharleston$4K
- Cristina EddyCharleston$4K
- Benjamin ChapmanCharleston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.